Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest congenital heart disease Stories

2012-01-19 14:25:00

SynCardia Total Artificial Heart was the “Perfect Solution” for Near-Death Patient with Ventricular Septal Defect Tucson, Ariz. (PRWEB) January 19, 2012 SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that on Dec. 29, 2011, University Medical Center (UMC) Ljubljana discharged Slovenia´s first Total Artificial Heart patient, 61-year-old Nikola GaÅ¡pič, to wait for a matching donor heart at home...

2011-12-14 10:20:27

More than one baby in every 50 is born with a birth defect (congenital anomaly) according to the latest annual report by the British Isles Network of Congenital Anomaly Registers (BINOCAR) — significantly more common than previously reported estimates of around one in 80. The study — led by researchers at Queen Mary, University of London and commissioned by the Healthcare Quality Improvement Partnership (HQIP) — is the most up-to-date and comprehensive of its kind,...

2011-11-21 11:31:00

ATLANTA, Nov. 21, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it will participate in the upcoming 23rd Annual Piper Jaffray Health Care Conference on Wednesday, November 30, 2011 at The New York Palace Hotel in New York City. Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present at 4:00 p.m. Eastern Time. CryoLife's...

2011-11-14 22:42:28

Adults with congenital heart disease and implanted cardioverter defibrillators (ICDs) often have a high level of fear and anxiety about the device delivering a shock during sex – resulting in sexual performance problems, according to research (Abstract 14165) presented at the American Heart Association's Scientific Sessions 2011. An ICD is an implanted, battery-powered device that monitors the heartbeat. If the ICD detects a dangerous irregular heartbeat, it delivers a shock to...

2011-11-03 07:34:00

ATLANTA, Nov. 3, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present in the upcoming Lazard Capital Markets Eighth Annual Healthcare Conference on Tuesday, November 15, 2011 at 3:00 pm ET in New York City. CryoLife is also scheduled to present at the Stephens, Inc Fall...

2011-10-28 04:43:00

JENA, Germany, October 28, 2011 /PRNewswire/ -- Occlutech, a leading European developer of septum occluders such as PFO and ASD devices as well as other innovative, minimally invasive cardiac implants, today announced that it got a favorable ruling in patent litigation with St Jude-AGA Medical from the District Court of Milan in Italy. In the ruling, the court stated that Occlutech is not infringing the Italian part of patent EP0808138 as alleged by St Jude-AGA Medical....

2011-10-19 05:31:39

(Ivanhoe Newswire) — More costly surgical procedures for adult congenital heart patients is associated with higher rates of inpatient death compared to surgical admissions that incur lower costs. Researchers sought to understand resource use by adults undergoing congenital heart surgery in pediatric hospitals, analyze the association between high resource use and inpatient death, and identify risk factors for high resource use. They found that although the number of adults...

2011-10-17 07:34:00

ATLANTA, Oct. 17, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today that 2011 third quarter financial results will be released on Thursday, October 27, 2011. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief...

2011-10-13 07:34:00

ATLANTA, Oct. 13, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that ValveXchange, Inc., a company in which CryoLife owns a minority interest, has completed the first three human implants with its novel Vitality(TM) two-part heart valve system. The surgeries were performed in Asuncion, Paraguay and took place on Sept. 26 and 27, 2011. Three men aged 49, 62 and 72 received...

2011-10-11 13:54:11

The US Secretary of Health recently supported a recommendation that all babies born in the US are to be screened for critical heart defects, before leaving hospital. Behind this decision is a study from the Sahlgrenska Academy at the University of Gothenburg, and the West Götaland Region's maternity units in Sweden which shows that a simple test can save the lives of newborns with these heart defects. Other countries too are set to make the test mandatory. One or two out of...


Latest congenital heart disease Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (1 articles) »